Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Clinical Trial
— COVINUTOfficial title:
Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (Covid-19) Status (Positive or Negative) During Hospitalization
Verified date | February 2023 |
Source | Gérond'if |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The principal aim of this interventional, multicentre study is to compare the impact of a follow-up by monthly telephone dietetic consultations, started 3 months after discharge from hospital, for a period of 3 months, on the energy intake in patients elderly people recently hospitalized for Coronavirus disease 2019 (Covid-19), Coronavirus disease Positive group "Covid (+)", or not, Coronavirus disease Negative group"Covid (-)". The main outcome measure is to compare the total energy intake at 6 months, after 3 months of dietary consultations, between Coronavirus disease Positive group "Covid (+)" and Coronavirus disease negative group "Covid (-)".
Status | Completed |
Enrollment | 34 |
Est. completion date | July 1, 2021 |
Est. primary completion date | April 22, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 75 Years and older |
Eligibility | Inclusion Criteria: - Patient hospitalized or having been hospitalized in acute geriatrics - Living at home 3 months after hospitalization in acute geriatrics - Having a good understanding of the French language - Being able to understand the study information and participate in telephone follow-up - Having read the information notice and agreeing to participate in the study - For the Covid (+) group: hospitalized for Covid-19 (diagnostic confirmation by positive RT-PCR) - For the Covid group (-): hospitalized for any other reason (negative RT-PCR) Exclusion Criteria: - Patient refusing to participate in the study - Subject to a legal protection measure (curatorship, guardianship or safeguard of justice) - With cognitive impairment making it impossible to understand the study protocol and express consent. |
Country | Name | City | State |
---|---|---|---|
France | Geriatric Department, Bichat, Beaujon and Bretonneau hospitals | Paris | IIe-de-France |
Lead Sponsor | Collaborator |
---|---|
Gérond'if |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison of total energy requirements, after 3 months of dietary consultations, between Covid (+) and Covid (-) groups. | A 30 to 40 minute telephone survey by a dietitian, with:
the reminder of food intake over 24 hours, estimation of the weight of each food and quantification in kcal / day and grams of protein / day. This assessment of food intake will be followed by nutritional advice adapted to the severity of undernutrition, spontaneous food intake, the subject's tastes and dislikes, and the possibilities of preparing the necessary dishes and textures. |
6 months | |
Secondary | Assessment of the degree of patient dependence according "Index of Independence in Activities of Daily Living" KATZ scale | This is a measurement of the subject's ability to perform activities of daily living independently without including minimum and maximum values | At inclusion | |
Secondary | Assessment of patient's level of dependence through an appreciation of instrumental activities of daily living according Lawton scale | Assessment of older people: Self-maintaining and instrumental activities of daily living without including minimum and maximum values | At inclusion | |
Secondary | Comparison of weight variation by measuring the Body Mass Index (BMI) | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04768998 -
Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)
|
||
Terminated |
NCT04642638 -
Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure
|
Phase 2/Phase 3 | |
Terminated |
NCT04940871 -
Study to Assess the Efficacy and Safety of Favipiravir-HU
|
Phase 2 | |
Completed |
NCT04588363 -
COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C
|
||
Completed |
NCT05249816 -
Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine
|
Phase 3 | |
Recruiting |
NCT04863547 -
Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection
|
||
Terminated |
NCT04389840 -
Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure
|
Phase 2/Phase 3 | |
Completed |
NCT04725084 -
Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome
|
||
Completed |
NCT04851821 -
The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)
|
Phase 1 | |
Withdrawn |
NCT05545319 -
A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19
|
Phase 2 | |
Terminated |
NCT04391309 -
COVID-19 and Anti-CD14 Treatment Trial
|
Phase 2 | |
Completed |
NCT04343261 -
Convalescent Plasma in the Treatment of COVID 19
|
Phase 2 |